ArticleHuman genetics2026
Sex differences and alcohol modulation in the heritability of MASLD: a twin study of the 2023 definition.
Article in Human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The baseline heritability of the newly defined metabolic dysfunction-associated steatotic liver disease (MASLD) is unknown. Given that sex and alcohol consumption are well-recognized determinants of fatty liver disease, it is important to understand whether they are also associated with variation in its underlying genetic susceptibility. We aimed to quantify the baseline heritability and investigate these potential effects in a classical twin study of 710 Chinese adults using structural equation modeling. We observed a baseline narrow-sense heritability (A) of 0.57 (95% CI 0.46-0.67) in the lower alcohol intake group. This genetic contribution was not uniform and showed a potential difference by sex, with heritability tending to be higher in females (0.63) than in males (0.30). Furthermore, the genetic architecture appeared to vary across alcohol exposure levels. In contrast to the additive (AE) model observed in lower drinkers, the higher alcohol intake group was better fitted by a dominant/non-additive (DE) model, yielding a broad-sense heritability (D) of 0.60 (95% CI 0.34-0.77). In conclusion, our findings suggest that the genetic architecture of MASLD may vary according to sex and alcohol consumption, highlighting potential gene-environment interactions and the context-dependent nature of genetic susceptibility. These results may have implications for future risk stratification and targeted prevention strategies.
Indexed as
Identifiers
42247012What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.